Tag: Pfizer
Pfizer: CEO Albert Bourla tested positive for Covid-19
(CercleFinance.com) – Albert Bourla, CEO of Pfizer, has been diagnosed with Covid-19, the American biopharmaceutical group announced on Monday. The business executive, who says he received four doses of the…
Pfizer: Positive results for pneumococcal vaccine
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Covid-19: EMA could approve a Pfizer vaccine targeting Omicron subvariants
Europe 1 with AFP 2:02 p.m., August 10, 2022modified to 4:16 p.m., August 10, 2022 The European Medicines Agency declared on Wednesday its desire to approve an anti-Covid vaccine from…
Valneva and Pfizer launch phase 3 study for their Lyme vaccine
(Update: details on the marketing authorization applications for the vaccine in the United States and Europe, background, comment from an analyst and Valneva’s stock price) PARIS (Agefi-Dow Jones)–The biotechnology company…
Pfizer buys Global Blood Therapeutics
By Jean-Noel Legalland Published on 08/08/2022 at 1:36 p.m. Photo credit © Reuters …
Nvidia pulls Nasdaq down: Dow stays positive
Nvidia pulls down Nasdaq Dow stays in the black 8/8/2022 10:53 p.m The US stock exchanges did not keep their opening gains on Monday, only the Dow Jones closed in…
Pfizer announces acquisition of Global Blood Therapeutics for $5.4 billion
Authorizations from GBT shareholders and the green light from the regulatory authorities are still awaited. The American pharmaceutical group Pfizer announced Monday the acquisition for approximately 5.4 billion dollars of…
Covid-19 After the United States, Israel authorizes the vaccination of toddlers with Pfizer and Moderna
The Israeli Ministry of Health announced on Tuesday that it has authorized babies and children between 6 months and 4 years old to be vaccinated against Covid-19. They will be…
Minus more than 20 percent: S&P 500 with a weak first half
minus more than 20 percent S&P 500 with a weak first half 06/30/2022, 10:44 p.m Interest rate concerns are gripping Wall Street. For the first half of the year, the…
Pfizer: New positive study data in Covid
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Valneva rises on the stock market, Pfizer will take 8.1% of the capital
No, it is not for its prospects in the development of a vaccine against Covid-19 that the Pfizer laboratory is interested in biotech Valneva, it hardly needs it, he who…
Pfizer confirms its entry into the capital of Valneva for 90.5 million euros
Agefi – Dow Jones | On 06/23/22 at 6:21 p.m. | Updated on 23/06/22 at 18:31 Pfizer confirms its entry into the capital of Valneva for 90.5 million euros |…